Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers
Introduction: Bromonidine tartarate ophthalmic solution (CAS registry-number: 70359- 46-5) is a relatively selective alpha-2 adrenergic agonist, indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Aim: The purpose of the present phase-1 cli...
Main Authors: | Hristova-Valcheva Ruska, Demircheva-Stojanova Irenna, Petrov Dimitrov Andrey, Gatchev Emil M., Friesinger Yroff Ursula, Richter Hagen Wolfram, Koytchev Krumov Rossen |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2018-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2018/2334-94921801581H.pdf |
Similar Items
-
The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
by: Ruiz Simonato Alonso, et al.
Published: (2020-03-01) -
Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs
by: Gen Suzuki, et al.
Published: (2020-01-01) -
Neuroprotective properties of Brimonidine
by: Т. N. Mikhailova
Published: (2019-11-01) -
Brimonidine-associated uveitis – a descriptive case series
by: Susanne Hopf, et al.
Published: (2020-12-01) -
Intravitreal brimonidine inhibits form-deprivation myopia in guinea pigs
by: Yifang Yang, et al.
Published: (2021-07-01)